Diprosalik, ointment for external application 30 g

Description

Composition
Active substance:
1 g of ointment contains:: betamethasone dipropionate 0.64 mg (equivalent to Betamethasone 0.5 mg), 30.0 mg of salicylic acid ;.
Excipients:
Liquid paraffin 100.0 mg Vaseline 869.36 mg.
Description:
Homogeneous ointment of soft consistency almost white, free of visible particles.
Product form:
Ointment for external use 0.05% + 3%. 30 g of the aluminum tubes treated with the epoxy varnish and closing membrane and the plastic screw-cap with a puncher for opening the membrane. According to one tube together with instructions for use in a cardboard package.
Contraindications
Hypersensitivity to any component of the drug.
Children under 2 years old.
Pregnancy (long-term treatment at high doses).
Lactation.
Rosacea, perioral dermatitis.
Bacterial, viral or fungal skin infection (pyoderma, syphilis, tuberculosis, skin, Herpes simplex, chickenpox, Herpes zoster, actinomycosis, blastomycosis, sporotrichosis).
Trophic ulcers in chronic venous insufficiency.
Skin tumors (cancer of the skin, nevi, atheroma, epithelioma, melanoma, hemangioma, xanthoma, sarcoma).
Skin reactions after vaccination.
Carefully.
Children up to age 12 years; liver failure; long-term treatment; applying to extensive areas of skin; the use of occlusive dressings.
Dosage
0.5 mg + 30 mg / g
Indications
Reduction of inflammatory manifestations dry and giperkeraticheskih dermatoses sensitive to therapy with corticosteroids, including – psoriasis, chronic atopic dermatitis, neurodermatitis (chronic simple stripping), lichen planus, eczema (including nummular eczema, eczema of the hands, eczematous dermatitis), pompholyx , seborrheic dermatitis of the scalp, ichthyosis and ichthyosiform other states.
Interaction with other drugs
Any interaction Diprosalik ointment preparation with other drugs is not registered.
Overdose
Symptoms. Long-term use of local corticosteroids in high doses can cause suppression of pituitary-napodchechnikovoy system function, leading to secondary adrenal insufficiency features and phenomena of Cushing, including Cushing’s syndrome. Prolonged use of high doses of drugs containing salicylic acid may lead to poisoning of salicylic acid.
Treatment. Displaying appropriate symptomatic treatment. Acute symptoms of Cushing’s usually reversible. If necessary – correction of electrolyte imbalance.
In the case of chronic toxicity recommended gradual elimination of corticosteroids. In overdose salicylates treatment also symptomatic. Measures should be taken for the early removal of salicylate from the body, e.g., ingestion of sodium bicarbonate (for alkalinization urine) and forcing diuresis.
pharmachologic effect
Pharmacological group:
Glucocorticosteroid + ectylotic.
Pharmacological properties:
Combination preparation based on two active ingredients – betamethasone dipropionate and salicylic acid. Betamethasone dipropionate – a synthetic fluorinated glucocorticosteroid (GCS) – anti-inflammatory, antipruritic and vasoconstrictive action.
When applied topically, salicylic acid possesses keratolytic and bacteriostatic and certain fungicidal action.
Pregnancy and breast-feeding
Due to the fact that the safety of local corticosteroids in pregnant women has not been established, the purpose of this class of drugs during pregnancy is only justified if the potential benefit to the mother outweighs the potential risk to the fetus.
Drugs of this class should not be used during pregnancy in high doses or for a long time.
Since up to now not clear whether the level of systemic absorption of sufficient local corticosteroids for the appearance of their determined concentrations in mother’s milk, it is necessary to stop any use of the drug, taking into account the extent to which its use is necessary for the mother.
Conditions of supply of pharmacies
Without recipe.
side effects
Adverse events that occurred with the use of local glyukokortiko steroids included the burning, itching, irritation, dryness, folliculitis, hypertrichosis, aknepodobnye eruptions, hypopigmentation, perioral dermatitis, allergicheskiykontaktny dermatitis, purpura, telangiectasia, local hirsutism, dermatitis, systemic side reaction (blurring of vision).
The following events occurred more frequently with the use of occlusive dressings: maceration of the skin, secondary infection, skin atrophy, striae and miliaria.
When adverse reactions that are not described in this manual, you should consult a doctor.
special instructions
Effect on driving ability.
It does not reveal any influence Diprosalik the drug’s ability to manage trans-tailors tools and use machines.
If during treatment with the drug developed hypersensitise or irritation, treatment should be discontinued. In the case of infection accession to assign appropriate therapy.
Systemic absorption of corticosteroids and salicylic acid when topically applied will be higher when using occlusive dressings, and also if the treatment undergo extensive body surface.
When systemic and local application of corticosteroids may experience blurred vision. When the complaints of blurred vision or other visual disturbances, should consult an ophthalmologist to assess the possible reasons that can include cataracts, glaucoma, serous chorioretinopathy.
With long-term drug treatment, it is recommended to gradually repeal.
The drug is not intended for use in ophthalmology. Avoid contact with the eyes and mucous membranes.
Storage conditions
Store at a temperature not higher than 25 C.
Keep out of the reach of children.
Dosing and Administration
Outwardly. Apply a thin layer 2 times a day – morning and night, completely covering the affected skin. Some patients supporting effect can be achieved by less frequent applications. Children aged 2 to 12 years – to put a thin layer on a small patch of skin 1 or 2 times a day for no more than 1 week.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist